Axsome Therapeutics, Inc. (AXSM)

184.70 +1.40 (+0.76%) USD  |  NASDAQ  |  Feb 18, 16:00
184.78 +0.08 (+0.04%) After-Hours: 20:00
More

Axsome Therapeutics Operating Income (Quarterly)

Operating Income (Quarterly) Chart

View Operating Income (Quarterly) for AXSM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Quarterly) Range, Past 5 Years

View Operating Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Quarterly) Benchmarks

View Operating Income (Quarterly) Benchmarks
Start Trial
Corcept Therapeutics, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade